International Policy Frameworks for Consent in Minimal-risk Pragmatic Trials (Papers: Tanya J. Symons, et al | November 2019)
Abstract There is intense debate around the use of altered and waived consent for pragmatic trials. Those in favor argue
Abstract There is intense debate around the use of altered and waived consent for pragmatic trials. Those in favor argue
Scientists are raising questions about the ethics of studies backed by Chinese surveillance agencies. Prestigious journals are taking action. BEIJING
Cartoon by Don Mayne www.researchcartoons.com
Disgraced surgeon Paolo Macchiarini, who faked research relating to dangerous and largely discredited tracheal transplants, has been handed a 16
Abstract The ability to generate human induced pluripotent stem cells (iPSCs) has opened new avenues for human disease modelling and
Scientists face an ethical dilemma over what to do with their ‘human bycatch’ To study wildlife, Dr. Nyeema Harris, an assistant
SAN FRANCISCO — Consumer genetics giant 23andMe announced Thursday that it would move deeper into the business of clinical trial